Securities Fraud
Not all investment losses are caused by market fluctuation. Some could be the result of financial or securities fraud. Misrepresentation or omissions regarding business, products, financial conditions or future prospects are violations of the Securities and Exchange Act of 1934 among other laws and can cost investors large losses. Here you will find a list and description of recent cases David B. Kahn & Associates, Ltd. is investigating on behalf of groups of investors against companies that allegedly reported false or misleading information.

We are currently accepting new clients in connection with these cases. If you have information which you believe would help us prosecute our case or if you are a shareholder interested in participating in a class action or shareholder derivative action, please contact us by either clicking on the "Contact Us" link or by filling out the shareholder information form found at the "Submit Your Information" Link.
COMPANY NAME

ArthroCare Corp.

Candela Corporation

Citigroup, Inc. on behalf of purchases of Auction Rate Securities

ETrade Financial Corp. on behalf of Purchasers of Auction Rate Securities

Humana, Inc.

JP Morgan Chase & Co. on behalf of Purchasers of Auction Rate Securities

Merck & Co., Inc.

Merrill Lynch & Co., Inc. on behalf of Purchasers of Auction Rate Securities

MoneyGram International, Inc.

Morgan Stanley on behalf of Purchasers of Auction Rate Securities

SunTrust Banks, Inc. on behalf of Purchasers of Auction Rate Securities

TETRA Technologies, Inc.

UBS AG on behalf of Purchasers of Auction Rate Securities

 CLASS PERIOD

8/4/06 - 1/23/08

2/1/06 - 8/21/06

                                   3/27/03-2/13/08   

                                      4/2/03 - 2/13/08

2/4/08 -3/11/08

                                           3/31/03 - 2/13/08

1/22/07 - 3/28/08

                                     3/25/03 - 2/13/08

1/24/07 - 1/14/08

                                           3/25/03 - 2/13/08

                                            4/1/03 - 2/13/08

1/3/07 - 10/16/07

3/21/03 - 2/13/08

        

The Private Securities Litigation Reform Act of 1995 (“PSLRA”) established the role of “lead plaintiff” to control securities fraud litigation. The PSLRA generally presumes that the investor or investor group with the largest financial stake in the litigation will serve as lead plaintiff and provides a time period for potential lead plaintiffs to step forward to lead the class. If you are a member of any of the classes described above, you may, no later than 60 days from the date posted in each summary, move the court to serve as lead plaintiff of the Class. In order to serve as lead plaintiff, however, you must meet certain legal requirements.

You may contact Mark King of David B. Kahn & Associates, Ltd. toll free at (800) 536-0499, or via e-mail (mking@kahnlawchicago.com), if you wish to discuss any of the actions described or if you have any questions concerning your rights or interests.
David B. Kahn & Associates, Ltd.
One Northfield Plaza, Suite 100 - Northfield, Illinois 60093-1211
Phone: (847) 501-5083 - Fax (847) 501-5086
e-mail: lawfirm@kahnlawchicago.com